MatthewI.QuesenberryMD

PubMed

• Acquired von Willebrand's Syndrome in a Patient with Concomitant Chronic Lymphocytic Lymphoma and Smoldering Multiple Myeloma.
  Lee, H., Haribhakti, N., Quesenberry, M., Reagan, J.> ;Rhode Island Medical Journal. 2024 Jan 4
• 2 citations
  Analysis of Hematology and Oncology Fellowship Website Content and Diversity Representation.
  Arun Muthiah, Vanya Aggarwal, Chandrasekar Muthiah, Chapman Wei, Thomas Ollila, Matthew I Quesenberry, Don S Dizon> ;JCO Oncology Practice. 2022 Apr 1
• 3 citations
  Critical Analysis of Hematology and Oncology Fellowship Web Sites in the United States.
  Jack H. Ruddell, Shaan A Ahmed, Oliver Y. Tang, Fred J. Schiffman, Matthew I. Quesenberry, Adam E.M. Eltorai> ;Journal of Oncology Practice. 2019 Apr 9
• 40 citations
  Intestinal microbiome analysis revealed dysbiosis in sickle cell disease.
  Seah H. Lim, Alison Morris, Kelvin Li, Adam Fitch, Loren D. Fast, Laura R. Goldberg, Matthew I. Quesenberry, Philippa G. Sprinz, Barbara Methé> ;American Journal of Hematology. 2018 Aug 1
• 6 citations
  Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With...
  Thomas A Ollila, Adam J. Olszewski, James N. Butera, Matthew I. Quesenberry, Peter J. Quesenberry, John L. Reagan> ;Clinical Lymphoma, Myeloma & Leukemia. 2018 Mar 1
• 22 citations
  Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study.
  Andrew Schumacher, William M. Sikov, Matthew I. Quesenberry, Howard Safran, Humera Khurshid, Kristen Mitchell, Adam J. Olszewski> ;Plos One. 2017 Feb 24
• 3 citations
  Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia
  John L. Reagan, Loren D. Fast, Martha Nevola, Kalyan Mantripragada, Arend Mulder, F H J Claas, Kayla Rosati, Andrew Schumacher, Howard Safran, C T Young, Matthew I. Qu...> ;Blood Cancer Journal. 2015 Dec 4
• 22 citations
  Cellular immunotherapy for refractory hematological malignancies
  John L. Reagan, Loren D. Fast, Howard Safran, Martha Nevola, Eric S. Winer, Jorge J. Castillo, James N. Butera, Matthew I. Quesenberry, Carolyn T Young, Peter J. Quese...> ;Journal of Translational Medicine. 2013 Jun 19
• 12 citations
  The human RGL (RalGDS-like) gene: cloning, expression analysis and genomic organization.
  Raman Sood, Izabela Makalowska, John D. Carpten, Christiane M. Robbins, Dietrich A. Stephan, Timothy D. Connors, Sharon D. Morgenbesser, Kui Su, Heather W. Pinkett, Ch...> ;Biochimica Et Biophysica Acta. 2000 Apr 25
• 18 citations
  Progressive juvenile-onset punctate cataracts caused by mutation of the gammaD-crystallin gene.
  D A Stephan, E Gillanders, D Vanderveen, D Freas-Lutz, G Wistow, A D Baxevanis, C M Robbins, A VanAuken, M I Quesenberry, J Bailey-Wilson, S H Juo, J M Trent, L Smith,...> ;Proceedings of the National Academy of Sciences of the United States of America. 1999 Feb 2
• Join now to see all

Abstracts/Posters

• BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
  Matthew I. Quesenberry, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019